Drugs in the Pipeline FDA Needs More Data on Tebipenem HBr for Complicated UTI By Brian Park, PharmD Publish Date June 28, 2022
News Testosterone Replacement Therapy Tlando Now Available By Brian Park, PharmD Publish Date June 7, 2022
News ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk Publish Date June 7, 2022
Drugs in the Pipeline Sparsentan Gets Priority Review for IgA Nephropathy By Brian Park, PharmD Publish Date May 17, 2022
News Zerbaxa Approved for Complicated Pediatric Intra-abdominal, Urinary Tract Infections By Brian Park, PharmD Publish Date April 26, 2022
News Renal Denervation Offers Sustained Blood Pressure Reduction By Natasha Persaud Publish Date April 12, 2022
Drugs in the Pipeline Enrollment Paused in Trials Evaluating BCX9930 for Complement-Mediated Diseases By Brian Park, PharmD Publish Date April 8, 2022
News Oral Tebipenem Effectively Treats Complicated UTI, Pyelonephritis By Natasha Persaud Publish Date April 7, 2022
Drugs in the Pipeline FDA Says No to Vadadustat Approval Due to Safety Concerns By Brian Park, PharmD Publish Date April 1, 2022
News FDA Approves Oral Testosterone Replacement Therapy Tlando By Brian Park, PharmD Publish Date March 30, 2022
Drugs in the Pipeline Positive Efficacy Findings Prompt Early Stop of Empagliflozin CKD Trial By Diana Ernst, RPh Publish Date March 16, 2022
Drugs in the Pipeline Cefepime-Taniborbactam Bests Meropenem in Complicated UTI Trial By Brian Park, PharmD Publish Date March 10, 2022
News MV140 Vaccine May Prevent Recurrent Urinary Tract Infections By Natasha Persaud Publish Date March 4, 2022
News Inappropriate Opioid, Gabapentinoid Prescribing in CKD Still a Problem By Natasha Persaud Publish Date March 1, 2022
Drugs in the Pipeline More Data Needed to Make Decision on Bardoxolone in Alport Syndrome By Diana Ernst, RPh Publish Date February 28, 2022
News FDA Clears First Condom Indicated for Anal Intercourse By Brian Park, PharmD Publish Date February 23, 2022